Molecular Diagnostics
Bio-Rad Launches Synthetic Negative and HAI Negative Run Controls
Bio-Rad Laboratories (Hercules, CA, USA) has launched two new Exact Diagnostics products: Synthetic Negative Run Control, which complements the Tick-borne, Meningitis/Encephalitis and Sexually-Transmitted Infections products; and HAI Negative Run Control, which complements the Hospital-Associated Infections products. More...08 Jul 2022
Portable HPV Test Enables Early Detection of Cervical Cancer at POC
A more accessible test, based on self-sampling, could increase cervical cancer screening in low-income or isolated populations, as well as among women in general who for a variety of reasons do not attend regular screenings. More...06 Jul 2022
Clinical Genomic Profiling Recommended for Bone Sarcoma Patients
The term “sarcoma” is shorthand for a complex family of more than 70 different diseases arising from connective tissue, independent of anatomic location, with each histology having unique natural history, biology, genetics, prognosis, and treatment. More...05 Jul 2022
Pocket-Sized Devices Enable Real-Time DNA and RNA Sequencing Anywhere
A new generation of sensing technology uses nanopores - nano-scale holes - embedded in high-tech electronics, to perform precise molecular analyses in fully scalable formats from pocket to population-scale devices. More...05 Jul 2022
System Separates Circulating Tumor Cells from Blood Samples, Improves Cancer Diagnostics
A new approach that can successfully and rapidly isolate rare circulating tumor cells from patient blood samples could help improve cancer diagnosis and the ability to provide targeted and personalized treatments. More...01 Jul 2022
New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
 Analyzer.jpg)
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Sample Transportation System
Tempus1800 Necto
In Other News
Turn-Key PCR Solution Enables On-Site, Near Patient Testing for Monkeypox Virus
Elevated Polyamine Levels in Urine and Saliva May Be Diagnostic for Head and Neck Cancer
Nanopore-based miRNA Analysis Detects Early Stage Bile Duct Cancer
Mobile Testing Platform Performs World's Fastest Multiplex PCR and RT-PCR Analysis
RT-PCR Test Detects Monkeypox Virus Delivers Results in 90 Minutes
Blood Test to Assess Nerve Damage Could Also Detect Alzheimer’s Years Before Onset
Electrochemical Sensor Platform to Enable New Diagnostic Tests in Near-Patient Settings
Molecular Tumor Profiling Benefits Pediatric Cancer Patients
First-Ever Blood Test Detects Parkinson’s Disease
Automated Liquid Biopsy Test Detects Advanced Breast Cancer in Five Hours
Blood Test Predicts Likelihood that Nonalcoholic Fatty Liver Disease Will Progress to Liver Cancer
High-Tech Method for Protein Biomarker Assay Testing to Revolutionize POC Diagnosis
Blood Test Detects Unique ‘Fingerprint’ of Early Onset of Diabetic Kidney Disease
Blood Test Can Determine Liver Disease Progression
Metabolism-Based Blood Test to Detect Multiple Cancer Types Prior to Symptoms
Simple Blood Test for Esophageal Cancer Could Reduce Invasive Endoscopy Procedures
Multiviral Pathogen Detection System to Revolutionize Rapid Infectious Disease Diagnosis and Tracking
POC Test Identifies and Differentiates Viral from Bacterial Acute Respiratory Infection in 10 Minutes
Rapid CE-Marked IVD Lung Cancer Test Delivers Results Within Three Hours
PCR System Moves Ultra-Fast Testing From Lab to Patients at Point of Need
Estimated Total Tumor mRNA Predicts Cancer Outcomes
Researchers Describe a Polygenic Risk Score that Predicts Likelihood of Developing Chronic Kidney Disease
Hand-Held Analyzer Provides Critical Sepsis Information in 11 Minutes at POC
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.